Mirati Therapeutics
MRTX
#3099
Rank
ยฃ3.13 B
Marketcap
ยฃ44.73
Share price
0.00%
Change (1 day)
38.43%
Change (1 year)

Mirati Therapeutics (MRTX) - Cash on Hand

Cash on Hand as of September 2023 : ยฃ0.74 B

According to Mirati Therapeutics's latest financial reports the company has ยฃ0.74 B in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Mirati Therapeutics - Cash on Hand chart (from 2005 to 2023)

Cash on Hand by year

Year Cash on Hand Change
2022-12-31ยฃ0.89 B-18.7%
2021-12-31ยฃ1.10 B8.22%
2020-12-31ยฃ1.01 B225.57%
2019-12-31ยฃ0.31 B79.12%
2018-12-31ยฃ0.17 B56.45%
2017-12-31ยฃ0.11 B142.73%
2016-12-31ยฃ45.97 M-44.24%
2015-12-31ยฃ82.46 M338.07%
2014-12-31ยฃ18.82 M-49.92%
2013-12-31ยฃ37.58 M64.33%
2012-12-31ยฃ22.87 M25.46%
2011-12-31ยฃ18.22 M281.06%
2010-12-31ยฃ4.78 M-53.95%
2009-12-31ยฃ10.38 M-52.79%
2008-12-31ยฃ22 M-28.37%
2007-12-31ยฃ30.71 M6.61%
2006-12-31ยฃ28.81 M120.03%
2005-12-31ยฃ13.09 M-27.1%
2004-12-31ยฃ17.96 M34.06%
2003-12-31ยฃ13.39 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
ยฃ0.29 B-60.48%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.1 M-99.99% Bahamas